Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).
about
Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentratesFactor VII Deficiency: Clinical Phenotype, Genotype and TherapyDiagnosis and Treatment of von Willebrand Disease and Rare Bleeding DisordersPrinciples of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalySustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVIIHeterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent maleElevated prothrombin time on routine preoperative laboratory results in a healthy infant undergoing craniosynostosis repair: Diagnosis and perioperative management of congenital factor VII deficiencyRecombinant activated factor VII in clinical practice: a 2014 update.Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.Long-term prophylaxis in severe factor VII deficiency.Spontaneous chronic subdural hematoma in young adult: the role of missing coagulation facto.Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency.Inhibitors to factor VII in congenital factor VII deficiency.A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.Congenital Factor Deficiencies in Children: A Report of a Single-Center Experience.Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory.Recurrent Bleedings in Newborn: A Factor VII Deficiency Case Report.
P2860
Q27026389-FD0780BC-6B1D-4C17-9DAF-C2003AE5DA3BQ33608210-66C7762D-BC9D-4281-BBC3-483A4CD954C4Q33608224-0C05E04A-6996-4C02-9C89-4420375C0320Q34416394-43E1814C-DDB1-494D-B08E-2E679A3ECD52Q36547796-05CDB546-C332-4E04-AF1A-8A81C33B6243Q36921588-E77DDC1F-6D06-4F0C-881E-4CDD6E77747BQ36946844-78EDFF84-1817-44B8-B858-B9FB9F626E5EQ38228494-5923FDEB-1B04-4BCF-AB72-AD0297AF246EQ39659820-A65C2CF8-8F8F-4B35-AA2E-CFAD0CDBBF47Q40963322-24EBCCFB-3CBF-412F-9A27-5B4CF175C1D4Q41008018-2C3B3349-9F5E-443A-A9BA-BD6463E8B630Q45738767-ADA0BF0D-473A-4B30-AB1F-773AC6EDDCE2Q45862546-F5AADCB4-F20E-4EDC-8ADD-8C0F1DFD04FAQ45863434-A10B6951-8CB3-4B69-BE85-470785064B89Q45873373-A5C7EC6C-08B1-45FC-B2C2-2B349D3213C3Q45882650-9A123998-2301-4E4C-9328-C1326EF19E54Q55239812-CDE4683A-80FE-4525-A5DF-5442E2F62FC5
P2860
Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prophylaxis in congenital fact ...... nt Evaluation Registry (STER).
@en
type
label
Prophylaxis in congenital fact ...... nt Evaluation Registry (STER).
@en
prefLabel
Prophylaxis in congenital fact ...... nt Evaluation Registry (STER).
@en
P2093
P2860
P50
P1433
P1476
Prophylaxis in congenital fact ...... ent Evaluation Registry (STER)
@en
P2093
Alberto Dolce
Ampaiwan Chuansumrit
Carmen Altisent
Guenter Auerswald
Guglielmo Mariani
Jens Bjerre
Jørgen Ingerslev
Lisa Michaels
Mariasanta Napolitano
Muriel Giansily-Blaizot
P2860
P304
P356
10.3324/HAEMATOL.2012.074039
P577
2013-02-12T00:00:00Z